SIGNIA TRI-STAPLE 2.0 BLACK 60MM EXTRA THICK RELOA, SIG60AXT
FDA Device Recall #Z-1834-2019 — Class II — May 17, 2019
Recall Summary
| Recall Number | Z-1834-2019 |
| Classification | Class II — Moderate risk |
| Date Initiated | May 17, 2019 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Covidien LLC |
| Location | North Haven, CT |
| Product Type | Devices |
| Quantity | 3,113,280 |
Product Description
SIGNIA TRI-STAPLE 2.0 BLACK 60MM EXTRA THICK RELOA, SIG60AXT
Reason for Recall
The device may be missing one of two pin components that maintain alignment of the device jaws, resulting in incomplete staple formation which may lead to bleeding, anastomotic leak, peritonitis, or pneumothorax which can result in the potential for infection and/or sepsis.
Distribution Pattern
Nationwide domestic distribution, worldwide foreign distribution.
Lot / Code Information
N6C0533UX N6C0582UX N6C0657UX N6C0681UX N6E0115UX N6E0116UX N6E0976UX N6E0977UX N6E0978UX N6E0979UX N6F0045UX N6F0046UX N6F0047UX N6F0048UX N6F0049UX N6F0050UX N6F0295UX N6F0503UX N6F0504UX N6F0505UX N6F0506UX N6F0507UX N6F0508UX N6F0509UX N6F0748UX N6F0758UX N6F0759UX N6F0760UX N6F0786UX N6F0787UX N6F0788UX N6G0068UX N6G0270UX N6G0271UX N6G0287UX N6G0288UX N6G0486UX N6G0499UX N6G0784UX N6G0785UX N6G0786UX N6H0105UX N6H0106UX N6H0107UX N6H0155UX N6H0156UX N6H0157UX N6H0173UX N6H0174UX N6H0298UX N6H0299UX N6H0302UX N6H0522UX N6H0693UX N6H0734UX N6H0909UX N6H0946UX N6J0040UX N6J0092UX N6K0302UX N6K0970UX N6K1067UX N6L0152UX N6M0328UX N7A0170UX N7C0475X N7C1091X N7C1092X N7D0104X N8A0087X N8D0035X N8D0225X
Other Recalls from Covidien LLC
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1557-2026 | Class II | HealthCast "Vital Sync" Remote Patient Monitori... | Jan 30, 2026 |
| Z-1775-2022 | Class II | Puritan Bennett 560 Ventilator, PB560, CFN 4096600 | Aug 19, 2022 |
| Z-1318-2022 | Class I | Palindrome SI Chronic Catheter, Sterile, Single... | Jun 8, 2022 |
| Z-1319-2022 | Class I | Palindrome HSI Chronic Catheter, Sterile, Singl... | Jun 8, 2022 |
| Z-1315-2022 | Class I | Palindrome Precision HSI Chronic Catheter, Ster... | Jun 8, 2022 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.